Advertisement

Topics

HeartSine Technologies, Ltd. Company Profile

22:35 EDT 26th July 2017 | BioPortfolio


News Articles [374 Associated News Articles listed on BioPortfolio]

HeartSine Technologies, LLC Strategic SWOT Analysis Review [Report Updated: 12072017] Prices from USD $125

HeartSine Technologies, LLC Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a de...

Physio-Control Launches HeartSine Samaritan PAD 360P Automated External Defibrillator In United States

  Life Sciences Jobs   ...

DBV Technologies: DBV Technologies Reports March 31, 2017 Cash Position

Press Release Montrouge, France, April 28, 2017 DBV Technologies Reports March 31, 2017 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announ...

DBV Technologies: DBV Technologies Reports Full Year 2016 Financial Results

Press Release Montrouge, France, March 15, 2017 DBV Technologies Reports Full Year 2016 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today an...

DBV Technologies : Publie son Document de Référence 2016 et son « Form 20-F »

DBV Technologies — Wednesday, March 22nd 2017 at 9:30pm UTC Communiqué de Presse Montrouge, France, 22 mars 2017, 23h30 CET DBV Technologies Publie son Document de Référence 2016 et son « F...

Agilent acquires Cobalt, expanding value for pharma and biopharma

Specialist in analytical laboratory technologies, Agilent Technologies, has acquired Cobalt Light Systems, which develops products and technologies for non-invasive, through-barrier chemical analysis ...

DBV Technologies: DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors

Press Release Montrouge, France, June 15, 2017 DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Mar...

DBV Technologies publie sa position de trésorerie au 31 mars 2017

DBV Technologies — Friday, April 28th 2017 at 5:30am UTC Communiqué de Presse Montrouge, France, le 28 avril 2017, 7h30 CEST DBV Technologies publie sa position de trésorerie au 31 mars 2017 D...

PubMed Articles [408 Associated PubMed Articles listed on BioPortfolio]

Changing Memories: Between Ethics and Speculation.

Over the past decade, a debate has emerged between those who believe that memory-modulating technologies are inherently dangerous and need to be regulated and those who believe these technologies pres...

Advanced technologies for the remediation of pesticide-contaminated soils.

The occurrence of pesticides in soil has become a highly significant environmental problem, which has been increased by the vast use of pesticides worldwide and the absence of remediation technologies...

Enhancing the Gaming Experience Using 3D Spatial User Interface Technologies.

Three-dimensional (3D) spatial user interface technologies have the potential to make games more immersive and engaging and thus provide a better user experience. Although technologies such as stereos...

Research Translation and Emerging Health Technologies: Synthetic Biology and Beyond.

New health technologies are rapidly emerging from various areas of bioscience research, such as gene editing, regenerative medicine and synthetic biology. These technologies raise promising medical po...

Technologies to Support Community-Dwelling Persons With Dementia: A Position Paper on Issues Regarding Development, Usability, Effectiveness and Cost-Effectiveness, Deployment, and Ethics.

With the expected increase in the numbers of persons with dementia, providing timely, adequate, and affordable care and support is challenging. Assistive and health technologies may be a valuable cont...

Clinical Trials [298 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Longitudinal Study of Chronic Wounds Using Novel Wound Measurement Technologies

An open, non-randomised longitudinal study of diabetic foot ulcers receiving standardised treatment, over a 16 week period conducted at out-patient level, utilising novel optical wound mea...

Companies [1212 Associated Companies listed on BioPortfolio]

HeartSine Technologies, Inc.

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the developm...

HeartSine Technologies

A world leader in personal and public access defibrillators, HeartSine's mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the developm...

HeartSine Technologies, Ltd.

HeartSine™ Technologies, Inc.

As a world leader in personal and public access cardiac rhythm management, our mission is to advance the deployment of lifesaving defibrillation therapy in non-traditional areas of care through the de...

CA Technologies

CA Technologies (NASDAQ: CA) is an IT management software and solutions company with expertise across all IT environments - from mainframe and distributed, to virtual and cloud. For additional inf...

More Information about "HeartSine Technologies, Ltd." on BioPortfolio

We have published hundreds of HeartSine Technologies, Ltd. news stories on BioPortfolio along with dozens of HeartSine Technologies, Ltd. Clinical Trials and PubMed Articles about HeartSine Technologies, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HeartSine Technologies, Ltd. Companies in our database. You can also find out about relevant HeartSine Technologies, Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record